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A large family from a small village in Madagascar, Antanetilava, is known to present
with colored teeth. Through previous collaboration and 4 successive visits in 1994,
2004, 2005, and 2012, we provided dental care to the inhabitants and diagnosed
dentinogenesis imperfecta. Recently, using whole exome sequencing we confirmed the
clinical diagnosis by identifying a novel single nucleotide deletion in exon 5 of DSPP.
This paper underlines the necessity of long run research, the importance of international
and interpersonal collaborations as well as the major contribution of next generation
sequencing tools in the genetic diagnosis of rare oro-dental anomalies. This study is
registered in ClinicalTrials (https://clinicaltrials.gov) under the number NCT02397824.
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INTRODUCTION
Dentinogenesis imperfecta (DI) belongs to a group of rare genetic diseases affecting the
formation/mineralization of tooth dentin and is transmitted, as recorded so far, in an autosomal
dominant manner (Barron et al., 2008). A dominant negative effect of a modified dentin
sialophosphoprotein (DSPP) has been suggested as the pathogenic mechanism underlying DI
(Wang et al., 2011).
These disorders exist either in isolation, with clinical manifestations limited to the oral cavity
and are named dentinogenesis imperfecta type II (DGI-II) or hereditary opalescent dentin (OMIM
#125490) also called dentinogenesis imperfecta 1 (DGI-1) or Capdepont teeth, and dentinogenesis
imperfecta type III (DGI-III; OMIM # 125500) (Shields et al., 1973; Kim and Simmer, 2007; Barron
et al., 2008; de la Dure-Molla et al., 2015). They can be associated with other symptoms like
progressive sensorineural hearing loss (OMIM # 605594) (Xiao et al., 2001) or encountered in
syndromes like osteogenesis imperfecta and Goldblatt syndrome for example in which bone defects
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(a tissue similar to dentin) are key features of the clinical synopsis
(Bloch-Zupan et al., 2012; Bloch-Zupan, 2014). Mutations
described so far occur in one single gene DSPP (4q21.3),
belonging to the SIBLINGs family and encoding threemajor non-
collagenous dentin matrix proteins- dentin sialoprotein (DSP),
dentin glycoprotein (DGP) and dentin phosphoprotein (DPP)
(Zhang et al., 2001; MacDougall, 2003; Kim et al., 2005; Lee et al.,
2008, 2009, 2011a, 2013).
In this paper, we focus on a large family from a small
village in Madagascar, Antanetilava, known to present with
colored teeth. The aim of the study is, through phenotyping
and genotyping, to unravel the diagnosis and genetic origin
of this rare familial condition. Through previous collaboration
(1996) and successive visits in 2004, 2005 and 2012, we provided
dental care to the inhabitants and linked the discoloration
diagnosis to dentinogenesis imperfecta. Recently, using whole
exome sequencing we confirmed this diagnosis by identifying a
novel DSPPmutation segregating with the disease in this family.
MATERIALS AND METHODS
Patients
In 1996 (Razafindrakoto et al., 1996), the Strasbourg Faculty
of Dentistry and the INSERM_U424 (JV Ruch) were contacted
by colleagues from l’IOSTM (Institut d’Odonto-Stomatologie
Tropicale de Madagascar) of Mahajanga University to help
in disseminating scientific data related to a specific family
originating from the small isolated village of Antanetilava
(18◦58′42.2′′S 47◦14′01.9′′E), in the middle of the luxuriant
tropical forest, in the Toamasina province, located 40 km North-
West from the city of Toamasina. This region on the East coast
of Madagascar is known for its hot and humid climate. It is a
rural area devoted essentially to agriculture where rice, manioc,
potatoes, banana and yam are cultivated. Colleagues visited
Antanetilava in 1994, when a total of 110 inhabitants lived there.
Problems related to inherited tooth anomalies in the population
of Antanetilava had been previously noticed and the aim of this
first visit was to determine what the tooth defects were, to follow
the disorder in the families and to estimate its frequency.
At that time 50 people (28 females and 22 males) belonging
to 22 of 26 households in the village were examined. Eleven
individuals (22%, 6 females and 5 males) presented with this
colored teeth anomaly affecting both the primary and permanent
dentition. Clinical examination revealed brown to blue-gray
discoloration of the crowns. Severe attrition due to early enamel
chipping was visible. A clinical diagnosis of dentinogenesis
imperfecta type II was proposed. Radiographic examination was
possible for one 23 year-old patient in the nearest local hospital
of Toamasina. Progressive pulp chamber obliterations as well as
absent root canals were noticed, confirming the diagnosis. A first
pedigree was drawn and demonstrated that the genetic disease
affected 5 generations and 46.7% of the family members.
After a 2004 preparatory mission, JM returned to Mahajanga
and visited Antanetilava in 2005 after a difficult journey
consisting of 6 h of bus, 8 h of bush taxi, 1 dugout canoe river
crossing and a further hour of walking.
Twenty seven participants (25 affected) and 2 non-
affected family members were examined during this 2005
visit. Affected and unaffected family members gave written
informed consent and, the study was approved by the village
council. The orodental phenotypes were documented using the
D[4]/phenodent registry: a Diagnosing Dental Defects Database
(see www.phenodent.org, to access assessment form). This
registry allows the standardization of data collection and assists
in orodental phenotyping. It also facilitates providing clinical
care to patients, a basis for genotype/orodental phenotype
correlations, and sharing of data and clinical material between
clinicians. D[4]/phenodent registry is approved by CNIL (French
National commission for informatics and liberty) under the
following number 908416.
This clinical study has been registered in Clinical trials
(https://clinicaltrials.gov) under the number NCT02397824 and
is registered by the FrenchMinistère de l’enseignement supérieur
et de la recherche, DGRI/Cellule de bioéthique (bioethics
committee) under DC-2012-1677. It was acknowledged by the
CPP (person protection committee) Est IV on the 11/12/2012.
Mutation Analysis
JM collected DNA samples using Whatman FTA cards and
Oragene R© DNA kits.
Genomic DNA was isolated from the saliva of 14 family
members (9 affected and 5 unaffected), during the 2012 mission,
using the prepIT-L2P OG-250 Oragene R© DNA kit (DNA
Genotek Inc., Ontario, Canada) according to standard protocols.
A few attempts of direct DSPP Sanger sequencing were
unsuccessful.
We performed whole-exome sequencing (IntegraGen, Evry,
France) for five affected patients (III.15, III.32, IV.26, IV.57,
and IV.65) and one healthy individual (IV.22). Exons of
DNA samples were captured using in-solution enrichment
methodology (SureSelect Human All Exon Kits Version 3,
Agilent, Massy, France) with the company’s biotinylated
oligonucleotide probe library (Human All Exon v5+UTR—
75 Mb, Agilent). The genomic DNA was then sequenced on
a sequencer as paired-end 2X75 base pair reads (Illumina
HISEQ2000, Illumina, San Diego, USA) resulting in an average
coverage of 200X. Image analysis and base calling was performed
using Real Time Analysis (RTA) Pipeline version 1.9 with default
parameters (Illumina). The bioinfomatic analysis of sequencing
raw data was based on the pipeline provided by the company
(CASAVA 1.8, Illumina and finally detects from 80965 to 82263
variants (SNPs and Indels) per proband (Table 1). Annotation,
ranking, and filtering of genetic variants were performed with
the VaRank program (Geoffroy et al., 2015). Very stringent
criteria were used for excluding non-pathogenic variants, in
particular: (1) variants represented with an allele frequency of
more than 1% in dbSNP 138, the EXAC database or the NHLBI
Exome Sequencing Project Exome Variant Server (EVS), (2)
variants found at the homozygous state or more than once at
the heterozygous state in 48 control exomes, (3) variants in
the 5′ or 3′ UTR, (4) variants with intronic locations and no
prediction of local splice effect, and (5) synonymous variants
without prediction of local splice effect.
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TABLE 1 | Summary of the exome sequencing results.
Individuals III.15 III.32 IV.22 IV.26 IV.57 IV.65
Type of sequence variant SNV Indel SNV Indel SNV Indel SNV Indel SNV Indel SNV Indel
Total number of variants 72429 9001 72273 8692 72638 8960 73233 9030 72480 8908 72212 8970
After exclusion of non-pathogenic variants (as
determined from the ClinicalSignificance field in
dbSNP) validated by at least 2 methods in dbSNP (as
determined from the “Validation Status” field)
8767 4955 8617 4658 8745 4898 8758 4940 8576 4812 8564 4852
After exclusion of variants with an allele frequency >
1% (extracted from the EXAC database, the Exome
Variant Server and the dbSNP database)
5734 3122 5653 3035 5792 3117 5703 3162 5675 3106 5648 3091
After exclusion of variants found in the homozygous
state or more than once in the heterozygous state in
70 control exomes
1972 843 1998 910 2041 888 1990 901 2115 923 2234 884
After exclusion of 5′UTR, 3′UTR, downstream,
upstream and intron locations without local splice
effect prediction (from the “localSpliceEffect” field of
Alamut-Batch)
767 123 729 132 757 119 706 120 731 122 780 119
After exclusion of synonymous variants without local
splice effect prediction (from the “localSpliceEffect”
field of Alamut-Batch)
571 123 563 132 571 119 520 120 569 122 592 119
Selection of variants consistent with recessive
transmission
0 compound heterozygous
0 homozygous variants
Selection of variants consistent with dominant
transmission.
4 heterozygous variants (in the DSPP, ABHD14A-ACY1, ABHD14A, HERC6 and THAP9 genes)
Sanger sequencing (GATC Biotech, Applied Biosystems
ABI 3730xlTM, Konstanz, Germany) was used to validate
the mutations and verify segregation using the following
primers.
Specific forward (F) and reverse (R) primers were designed
to amplify the DSPP exon 5 region containing the mutation:
DSPP-F (GTGACAGCAGCAATAGCAGTGATA) and DSPP-R
(TCACTGGTTGAGTGGTTACTGTC) (expected product size
of 376 bp (base pair). PCR amplifications were performed in
a final volume of 50µl containing 0.2µM forward and reverse
primers, 0.2mM dNTPs, 1X GoTaq reaction buffer containing
1.5mMMgCl2, 1.25 unit of GoTaq DNA polymerase (Promega),
50 ng of template DNA and 3% DMSO. Amplifications were
performed for 40 cycles, each consisting of 30s denaturation at
94◦C, 30s annealing at 64.9◦C and 17s elongation at 72◦C.
RESULTS
Clinical Phenotype
The family history and pedigree, as established in 1996, was
updated. It then included 137 individuals spanning 5 generations
(Figure 1) and 4 related families. 55 individuals, 31 males and
24 females, were reported as affected and presenting with DI
corresponding to a 40.1% prevalence of the disease within this
population (1/2 in generation I, 2/3 in generation II, 4/13 or
30.8% in generation III, 16/25 (64%) in IV, 30/64 (46.9%) in V
and 2/7 (28.6%) in VI).
Medical history was collected from the 25 affected of the
27 examined persons. Patients reported only infectious episodes
like malaria, measles, and fever. Some affected individuals (3)
presented a triangular face shape or a facial asymmetry. Most of
affected persons (23) showed blue sclera. Disturbance of hearing
was recorded for 5 affected individuals. 9 patients presented
articular distortions or pain and 3 had nail dysplasia.
Dental history mentioned infections, early tooth mobility and
loss and tooth extractions. Both the primary and permanent
dentitions were affected. Teeth presented with the amber-gray
color pathognomonic of heritable dentin defects (Figure 2).
Some tooth shape/size anomalies were observed as scoop shaped
incisors, absence of convex vestibular crown surface, flat aspect
of crown occlusal surfaces and supernumerary cusps. Enamel,
when visible, presented an irregular appearance. Tooth wear was
considerable and was visible via the colored abnormal dentin
after enamel shedding. Fifteen individuals (11 adults, 4 children)
suffered from tooth mobility. Nine individuals experienced
dental infections. A probable diagnosis of DI was made.
Three affected patients benefitted from X-ray investigations
through intraoral radiographs taken in a private practice in the
Antananarivo town. These pictures showed complete pulp space
obliteration and globular crowns with cervical constrictions
(Figure 2) confirming the diagnosis.
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FIGURE 1 | Family pedigree. A large pedigree, spanning 5-generations with 137 individuals, of which 55 are affected, is showing a dominant inheritance pattern.
Arrows point to individuals whose exomes were sequenced (affected: III.15, III.32, IV.26, IV.57, IV.65; non-affected: IV.22). Sanger sequencing was performed for the
following subjects: affected (III.15, III.32, III.33, IV.25, IV.26, IV.57, IV.59, IV.64, IV.65), non-affected (III.16, III.37, IV.21, IV.22, IV.23).
FIGURE 2 | Clinical description of the disease. (A) The remote village of Antananarivo. (B–J) Inhabitants’dentition showing the typical features of dentinogenesis
imperfecta with the gray-brown discolouration of the dentin clearly visible after enamel cleavage and progressive tooth wear. (C) On the retro-alveolar radiography of
the lower right premolar/molar sector of individual (B), cervical constriction, short roots and the disappearance of pulp spaces due to erratic dentin formation
represent the characteristic hallmarks of dentinogenesis imperfecta. (H–J) In addition to dentin anomalies, hypoplastic enamel defects exist, with the presence of pits,
striae and flattened buccal surfaces.
Genotype
Using VaRank, to annotate rank, and filter the genetic variants,
we identified, amongst 80965–82263 variants (SNPs and Indels)
per proband, four candidate variants in five genes (DSPP
[dentin sialophosphoprotein, OMIM: 125485], ABHD14A-ACY1
[ABHD14A-ACY1 readthrough (NMD candidate)], ABHD14A
[abhydrolase domain containing 14A], HERC6 [HECT and RLD
domain containing E3 ubiquitin protein ligase family member
6, OMIM: 609249] and THAP9 [THAP domain containing 9,
OMIM: 612537]) with heterozygous variants present only in the
affected patients (Table 1).We then focused the subsequent study
on the heterozygous variant inDSPP, a known causal gene for DI:
a heterozygous deletion (c.3676del [p.Ser1226Alafs*88] [RefSeq
NM_014208.3]). Mutation is absent from the 1000 genome,
NHLBI EVS and ExAC databases.
We identified through exome sequencing and confirmed by
bidirectional Sanger sequencing analysis ofDSPP, a heterozygous
deletion of 1 base pair (bp) in exon 5 (p.[Ser1226Alafs∗88];[=]
or c.[3676delA];[=]) in 9 affected patients (Figure 3).
Segregation analysis validated the absence of the mutation
in unaffected individuals. The deletion was absent from
dbSNP and the Exome Variant Server. These mutations
are predicted to cause a frameshift from codon Ser1226
producing an early stop codon 87 amino acids after the
deletion and deleting the protein of an important functional
domain.
DISCUSSION
This work is an extraordinary travel in time, human beliefs
and mutual assistance, genetics, science, and new technologies
allowing the understanding of the exceptional prevalence of DI
in this remote village from Madagascar. The family believed that
the tooth coloration and the disease was of nutritional origin.
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FIGURE 3 | DSPP mutation analysis. DSPP mutations are indicated against the gene structure (reference sequence: NM_014208.3). (A) Schematic representation
of DSPP: this gene contains 5 exons (vertical blue hatches), the position of the start codon (ATG) and the stop codon (TAG) are indicated respectively in exon 2 and
exon5. The known mutations in the DSPP gene are summarized against the gene structure and associated to a literature reference. The new mutation described in
this paper is boxed and written in red. For example: the most 5′ DSPP mutation, near the initiation codon (ATG) is lying in exon 2 and described as a single nucleotide
variant c.16T>G leading to the following amino acid changes in the protein p.Tyr6Asp and reported in the literature in quoted reference (Rajpar et al., 2002). (B)
Electrophoregrams of a part of DSPP exon 5 showing the heterozygous mutation in an affected person and the normal sequence in an unaffected individual. The
deletion of 1T is indicated with an arrow, this deletion creates a shift in the reading frame in position 3676 of the cDNA reference sequence, resulting in 2 superposed
sequences. On the scheme the numbering corresponds to the following references: 1. Rajpar et al. (2002); 2. Malmgren et al. (2004); 3. Xiao et al. (2001); 4. Zhang
et al. (2007) and Qu et al. (2009); 5. Hart and Hart (2007); 6. Mcknight et al. (2008a); 7. Li et al. (2012) and Lee et al. (2013); 8. Wang et al. (2009); 9. Lee et al. (2008);
10. Holappa et al. (2006); 11. Kim et al. (2004); 12. Kim et al. (2005); 13. Song et al. (2006); 14. Lee et al. (2011b); 15. Kida et al. (2009); 16. Lee et al. (2009); 17.
Zhang et al. (2001); 18. Wang et al. (2011); 19. Mcknight et al. (2008b); 20. Zhang et al. (2011); 21. Bai et al. (2010); 22. Nieminen et al. (2011); 23. Song et al. (2008);
24. Lee et al. (2011a); 25. Dong et al. (2005).
Some hypotheses were proposed like the large consumption
of red rice, or drinking habits (acidic water source). Oral
tradition of the family history described healthy ancestors.
Tradition forbids women, after giving birth, to eat white rice and
transgression of this law after a famine period was believed to be
associated with the appearance of the dental defect among the
population.
DI incidence is believed to reach 1 in 8000 individuals
according to Barron et al. (2008). Due to the founder effect, well
observed in generation I of the pedigree, and the geographic
isolation of the studied population, this prevalence approximates
40% in this population.
DI is transmitted as an autosomal dominant trait and this
is clearly visible with the parent to child transmission seen in
the pedigree and the presence of affected members in each
generation.
The medical history revealed hearing loss problems, which
indeed have been reported as associated with DI and DSPP
mutations (Xiao et al., 2001). Blue sclerae are a classical hallmark
of osteogenesis imperfecta clinical synopsis and the association of
DI with even a milder form of osteogenesis imperfecta was still a
possible diagnosis (Wang et al., 2012).
The phenotype demonstrated both enamel and dentin defects
as was previously also reported (Wang et al., 2011). Dspp is
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expressed by odontoblasts and transiently by preameloblasts
(Bronckers et al., 1993; Ritchie et al., 1997; Begue-Kirn et al.,
1998).
Difficulties throughout the years to sequence the DSPP gene,
especially the DPP region, are due to the high GC rich contents
and the number of repeats. As no mutation could be initially
detected in this candidate gene and because of disease high
frequency within this population we hypothesized that another
unidentified gene might be involved. Thus, we used exome
sequencing to look for the causative gene. But in fact, we
identified a novel single base pair deletion within the end of the
fifth DSPP exon leading to a premature stop codon. It has never
been described in the literature.
Thirty nine mutations in the human DSPP gene causing
dentin defects have been previously reported (Figure 3).
Mutations (mostly substitutions) leading to a DI (DGI)
phenotype are located mostly at the 5′ end of DSPP and also
seem to cluster in exon 2 and around the splice boundaries of
exon 3. In exon 5 at the 3′ end of DSPP, deletions causing frame
shift mutations were responsible for DGI and dentin dysplasia
(DD) (Wang et al., 2011). The mutation described herein is also
localized at the end of exon 5. This exon codes for DPP (dentin
phosphoprotein), which is one of themost abundant extracellular
matrix components in dentin (after collagen type I COL1A1,
COL1A2). DPP has a role in biomineralization by binding to
collagen and calcium and promoting the nucleation and growth
of hydroxyapatite crystals (Prasad et al., 2010). The discovered
mutation is predicted to cause a frameshift from codon Ser1226
producing an early stop codon 87 amino acids after the deletion,
depleting the protein of an important functional domain. This
domain is called “Asp/Ser-rich” by UniProt (position 439-1301).
To date, only one other mutation has been identified in the
3′ end of exon 5 (Dong et al., 2005) and consisted of a 36 bp
deletion and an 18 bp insertion with a phenotype of DGI type
III. Authors reported affected family members with amber tooth
discoloration, opalescent appearance, severe attrition of teeth,
visible pulp chambers and shell teeth on radiographs differing
from the DI phenotype reported in this paper.
Targeted next-generation sequencing technics for orodental
disorders (Prasad et al., 2016) prove to be efficient methods to
sequence DSPP gene allowing further mutations detection and
helping providing accurate molecular and clinical diagnosis to
rare disease patients. Differential clinical andmolecular diagnosis
betweenDI andmild forms of osteogenesis imperfecta presenting
with opalescent teeth is important and will orientate patients
toward appropriate integrated dental and medical care. These
methods, as associated costs decrease, will be transposed from
research results to diagnostic molecular findings.
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